SYNERGEYES HYBRID CONTACT LENS - KS KS6785-1450

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2014-06-09 for SYNERGEYES HYBRID CONTACT LENS - KS KS6785-1450 manufactured by Synergeyes.

Event Text Entries

[4565747] On (b)(4) 2014, synergeyes received a complaint wherein pt sustained a corneal ulcer in the right eye (od). Pt also experienced "slight irritation. " attending eye-care professional (ecp) prescribed tobradex for symptoms in the left eye (os). Complaint states that symptoms surfaced (b)(6) 2014, however "all symptoms have been resolved as of now. " wherein, "now" refers to (b)(6) 2014. From (b)(6) 2014, several attempts were made to obtain additional event information from ecp. On (b)(6) 2014, synergeyes spoke with dr (b)(6) regarding the event and pt. The following was disclosed: pt has a history of over wearing lenses. For example: pt wore last set of synergeyes lens for longer than one year, when the recommended length is 6 months, the lenses mentioned were ordered (b)(6) 2009. New lenses ordered in the same parameters on (b)(6) 2014 were uncomfortable for pt and pt developed redness and irritation with pain greater in od than in os. At a follow up visit, pt exhibited a "mechanical" sterile ulcer in the right eye just outside the junction. This cleared completely with treatment. A technician from the ecp practice called synergeyes consultation on (b)(6) 2014 and inquired about os lens turning eye "red. " synergeyes consultant instructed lab tech to switch lenses to see if problem followed lens to od or remained only in os. As instructed by dr (b)(6) this was never done. Instead, dr (b)(6) returned lenses and reordered the same prescription (rx) for both eyes, to verify if original lenses were "bad". Os rx was ordered on (b)(6) 2014 and od rx on (b)(6) 2014. Pt is doing well with new lenses for both eyes.
Patient Sequence No: 1, Text Type: D, B5


[12100241] Second device returned: model # ks6785-1550, lot #: 052049, expiration date: 06/01/2018, manufacture date: 07/01/2013. During the investigation, the following information was obtained. Device 1: base curve measured by radius scope and power measured by lensometer, both bc and power were found to be within specifications. No defects were noted on surface and no correlation was found between the alleged injury and the lens processing history. Device 2: base curve measured by radius scope and power measured by lensometer. Both bc and power were found to be within specifications. No defects were noted on surface and no correlation was found between the alleged injury and the lens processing history.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3005087645-2014-00014
MDR Report Key3883639
Report Source05
Date Received2014-06-09
Date of Report2014-06-06
Date of Event2014-03-20
Date Mfgr Received2014-05-12
Device Manufacturer Date2014-02-01
Date Added to Maude2014-06-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactKAREN KINCADE, DIRECTOR
Manufacturer Street2232 RUTHERFORD ROAD
Manufacturer CityCARLSBAD CA 92008
Manufacturer CountryUS
Manufacturer Postal92008
Manufacturer Phone7604449636
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSYNERGEYES HYBRID CONTACT LENS - KS
Generic NameCONTACT LENS
Product CodeHQD
Date Received2014-06-09
Returned To Mfg2014-05-12
Model NumberKS6785-1450
Lot Number056131
Device Expiration Date2019-01-01
OperatorLAY USER/PATIENT
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerSYNERGEYES
Manufacturer AddressCARLSBAD CA US


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2014-06-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.